Pibrentasvir

Molecular mass: 1,113.201 g/mol  PubChem compound: 58031952

Therapeutic indications

Pibrentasvir is indicated for:

Indication

Population group: only adolescents (12 years - 18 years old) , adults (18 - 65 years old)

Chronic viral hepatitis C

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Pibrentasvir is contraindicated in the following cases:

Contraindication

at least one of
Atazanavir
Atorvastatin
Simvastatin
Dabigatran
17 alpha-Ethinylestradiol
CYP3A4 inducers
Carbamazepine
Clotrimazole
Dexamethasone
Fosamprenavir
Indinavir
Morphine
Nelfinavir
Phenobarbital
Tipranavir
Spironolactone
Saquinavir
Ritonavir
Rifampicin
Prazosin
Phenytoin
Hypericum perforatum (St John's Wort)
13-CIS-12-(3'-CARBOXYPHENYL)RETINOIC ACID
Phenothiazines with aliphatic side-chain
Phenothiazines with piperazine structure
Phenothiazines with piperidine structure
Efavirenz
Darunavir
Lopinavir
Lovastatin
Omeprazole
Pregnancy

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈